The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.

Source: Int J Clin Pharm 2023 Feb 27; . doi: 10.1007/s11096-022-01528-yAuthors: Meaadi J, Obara I, Eldabe S, Nazar H

There are increasing concerns regarding the abusive potential of gabapentinoids putting at risk patients with neuropathic pain requiring long-term pain management. The evidence to support this is rather inconcusive.

Pubmed ID: https://pubmed.ncbi.nlm.nih.gov/36848024/